Antigenic polypeptide and use thereof
AssigneeAnda Biology Medicine Development (Shenzen) Co., Ltd.
InventorLandian Hu
Life of this patent
Estimating the term…
Abstract
Provided are an isolated polypeptide or an antigenic fragment thereof, an antibody binding to the isolated polypeptide or the antigenic fragment thereof, a composition including the isolated polypeptide or the antigenic fragment thereof, and an array including the isolated polypeptide or the antigenic fragment thereof. Further provided a method for detecting the presence of an antibody against SARS-COV-2 in a subject, a method for the prognosis of the subject infected with SARS-COV-2, a method for inducing an immune response against SARS-CoV-2 in a subject, and a method for preventing and/or treating a disease caused by SARS-COV-2 infection in a subject.
Claims21
1-50. (canceled)
A composition comprising a polypeptide having an amino acid sequence shown as SEQ ID NO:
- 10 or an antigenic fragment thereof or an amino acid sequence obtained after a substitution, a deletion, an insertion and/or an addition of one or more amino acid residues in SEQ ID NO:
- 10, and one or more of polypeptides having an amino acid sequence selected from amino acid sequences shown as SEQ ID NOs:
- 1-9 and 11-48 or antigenic fragments thereof or an amino acid sequence obtained after a substitution, a deletion, an insertion and/or an addition of one or more amino acid residues in any one of SEQ ID NOs:
- 1-9 and 11-48.
An array, comprising a solid substrate and a polypeptide immobilized on the solid substrate, wherein the polypeptide comprises at least one polypeptide having an amino acid sequence selected from a group consisting of the following amino acid sequences shown as SEQ ID NO:
- 40-48 or an antigenic fragment thereof or an amino acid sequence obtained after a substitution, a deletion, an insertion and/or an addition of one or more amino acid residues in any one of SEQ ID NO:
- 40-48.
Dependencies are inferred from the claim text.